Search

everythinglearnresearchcommunity

for

Search:↓

Intradermotherapy with minoxidil is as effective as topical application for treating hair loss.

The method accurately and quickly measures silodosin and dutasteride in mixtures.

The document concludes that current hair loss treatments have limitations and suggests researching new treatments targeting different factors of hair loss.

Oral Janus kinase inhibitors may be an effective treatment option for lichen planopilaris with some risk of increased cholesterol and liver enzyme levels.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Using 5α-reductase inhibitors for hair loss may increase the risk of dry eye disease.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

12-Methoxy carnosic acid from rosemary might be a good natural treatment for hair loss.

SRD5A2 methylation in blood can predict how well someone will respond to finasteride treatment.

Tofacitinib can cause unusual hair growth, requiring careful monitoring and possible laser hair removal.

5α-reductase affects dopamine receptors linked to sensorimotor gating, which may help understand disorders like schizophrenia.

Filgotinib completely reversed hair loss in a patient with rheumatoid arthritis and alopecia universalis.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

Equol may help with antiaging and skin health by boosting collagen and blocking certain hormones.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.

A man developed oral hairy leukoplakia while on baricitinib, a medication for alopecia and arthritis, and doctors should watch for such side effects.

Ticagrelor works better than clopidogrel in reducing platelet activity in elderly patients with acute coronary syndrome.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

JAK inhibitors show promise in treating difficult skin diseases.

The new delivery system improves treatment for hair loss by enhancing drug absorption and effectiveness.

Four drugs were found that could potentially treat COVID-19 by inhibiting the virus in lab tests.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

New compounds were found to help increase hair growth and decrease hair loss.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

JAK inhibitors effectively regrow hair in alopecia areata but hair loss often returns after stopping treatment.

5α-reductase inhibitors lower overall prostate cancer risk but not high-grade cancer risk; longer-term screening and new treatments show promise.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.